This site requires age verification. Please enable JavaScript to continue.

Need help? Text us, and a team member will reply in mins +1 (323) 393-3703

  • 24/7 Support
  • Free Shipping on Orders Over $299
  • Batch Produced, Batch Tested
  • Fast & Discreet Shipping
  • Affordable Pricing

PT-141

$49.00
Dosage
Nootropic Compound
In stock: 32 available
Product Details
Research Use Only
All products from Purple Peptides are for laboratory research use only, not for human or animal consumption. These materials are for in vitro research and must be handled by qualified professionals in controlled laboratory environments.

What Is PT-141?

PT-141, also known as Bremelanotide, is a synthetic melanocortin peptide originally developed from Melanotan II and extensively studied for its interaction with melanocortin receptors within the central nervous system.

Unlike many peptides investigated primarily for peripheral physiological activity, PT-141 has attracted significant scientific interest because of its relationship with neurobiological signaling pathways involved in motivation, behavior, autonomic regulation, and neuroendocrine communication.

Rather than being studied primarily through peripheral vascular mechanisms, PT-141 is investigated for its influence on central melanocortin receptor activity, providing researchers with a tool for examining how peptide signaling within the brain relates to complex physiological and behavioral responses.

PT-141 10mg Profile

Peptide Type
Synthetic cyclic melanocortin peptide
Vial Strength
10mg
Alternative Name
Bremelanotide
CAS Number
189691-06-3
Molecular Formula
C₅₀H₆₈N₁₄O₁₀
Molecular Weight
1,025.2 g/mol
PubChem CID
11949646
Primary Research Targets
MC4R and MC3R
Use
Laboratory research only

Primary Research Focus: Central melanocortin receptor signaling, neuroendocrine communication, hypothalamic signaling, autonomic regulation, behavioral neuroscience, and melanocortin receptor biology.

PT-141 Overview

PT-141 is a cyclic synthetic peptide derived from Melanotan II through structural modifications designed to optimize receptor activity while reducing melanogenic effects.

It primarily interacts with melanocortin receptors, particularly MC4R and, to a lesser extent, MC3R. These receptors are distributed throughout the central nervous system and participate in behavioral, neuroendocrine, metabolic, and autonomic signaling.

Current areas of investigation include:

  • Central melanocortin receptor signaling
  • Neuroendocrine communication
  • Behavioral neuroscience
  • Autonomic nervous system regulation
  • Hypothalamic signaling pathways
  • Dopaminergic network interactions
  • Motivation and reward circuitry
  • Brain-body communication

The Science Behind PT-141

The melanocortin system represents an important neuropeptide communication network involved in appetite regulation, energy balance, autonomic function, endocrine signaling, and complex behavioral responses.

These effects are mediated through a family of melanocortin receptors distributed throughout the central nervous system and peripheral tissues.

PT-141 has become an important investigational peptide because it activates central melanocortin receptors involved in neurological and neuroendocrine communication rather than functioning primarily through direct peripheral vascular pathways.

Laboratory research has investigated how melanocortin receptor activation may interact with downstream neurotransmitter systems, including dopaminergic and oxytocinergic networks involved in behavioral and neuroendocrine regulation.

Ongoing investigations continue to examine:

  • Melanocortin receptor signaling
  • Hypothalamic communication
  • Dopamine pathway regulation
  • Neuroendocrine signaling
  • Autonomic nervous system activity
  • Brain reward circuitry
  • Hormonal communication networks
  • Central nervous system peptide signaling

History & Development

PT-141 originated during research involving Melanotan II, a synthetic analog related to alpha-melanocyte-stimulating hormone (α-MSH).

During early investigations, researchers observed physiological activity extending beyond pigmentation-related pathways, prompting further investigation into the compound's interaction with central melanocortin receptors.

Subsequent structural refinement led to PT-141, which became an important research compound for investigating melanocortin receptor-mediated neurological pathways while reducing unwanted melanogenic activity.

Since its development, PT-141 has been studied across laboratory and clinical research involving neuroendocrine regulation, behavioral neuroscience, autonomic physiology, and melanocortin receptor biology.

PT-141 Structure

Alternative Name
Bremelanotide
Vial Strength
10mg
CAS Number
189691-06-3
Molecular Formula
C₅₀H₆₈N₁₄O₁₀
Molecular Weight
1,025.2 g/mol
PubChem CID
11949646
Research Receptors
MC4R / MC3R
Peptide Class
Cyclic melanocortin peptide

Current Areas of Research

Published scientific literature continues to investigate PT-141 across several disciplines within neuroscience and endocrine biology.

Neuroscience Research

  • Melanocortin receptor signaling
  • Central nervous system communication
  • Behavioral neurobiology
  • Dopaminergic pathway regulation
  • Reward system physiology

Neuroendocrine Research

  • Hypothalamic signaling
  • Brain-endocrine communication
  • Hormonal regulation pathways
  • Peptide neurotransmission

Autonomic Research

  • Autonomic nervous system regulation
  • Central autonomic signaling
  • Brain-body communication
  • Physiological homeostasis

Receptor Biology Research

  • MC3R receptor physiology
  • MC4R receptor signaling
  • Peptide-receptor interactions
  • Intracellular signaling mechanisms

Why Researchers Continue Studying PT-141

PT-141 remains an important investigational peptide because it provides researchers with a way to study how central peptide signaling influences physiology through the melanocortin system.

Rather than acting primarily on peripheral tissues, PT-141 provides insight into how the brain integrates hormonal, neurological, behavioral, and autonomic information through specialized melanocortin receptor networks.

Its characterized receptor activity and body of published research continue to make PT-141 a useful compound for laboratory investigations involving central nervous system signaling, receptor pharmacology, neuroendocrine biology, and autonomic regulation.

Purple Peptides Research Snapshot

Primary Research Focus
Central melanocortin receptor signaling
Primary Mechanism Studied
MC4R and MC3R receptor agonism
Published Human Studies
Yes
Animal Research
Yes
Cellular Research
Yes
First Published
Early 2000s
Research Maturity
Extensive
Vial Strength
10mg

Key Biological Pathways

  • Melanocortin Signaling
  • MC4 Receptor Activation
  • Neuroendocrine Communication
  • Dopaminergic Networks
  • Hypothalamic Signaling
  • Autonomic Regulation

Scientific References

View References
  • Hadley ME, et al. Peptides. 2001;22(4):595-600.
  • Wessells H, et al. Journal of Urology. 2000;164(2):389-393.
  • Diamond LE, et al. Journal of Sexual Medicine. 2004;1(1):74-82.
  • Kingsberg SA, et al. Obstetrics & Gynecology. 2019;134(5):899-908.
  • Cone RD. Nature Reviews Neuroscience. 2005;6(7):571-578.

Research Use Only

For Laboratory Research Purposes Only

This product is intended exclusively for laboratory research and analytical applications.

  • Not for human consumption
  • Not intended for diagnostic or therapeutic use
  • Not intended to prevent, treat, or cure disease

Products sold by Purple Peptides are intended exclusively for qualified research professionals and laboratory investigators for research use only.

Save this product for later
Share this product with your friends
PT-141

frequently purchased together